← Back to Search

Behavioural Intervention

Skills-Based VR for Finger Injury

N/A
Waitlist Available
Led By Ryan A Mace, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the study completion, approximately 1 year
Awards & highlights

Study Summary

This trial tests a VR program to help people w/acute orthopedic injuries. It measures feasibility, improvement, pain mechanisms, & user experience.

Eligible Conditions
  • Finger Injury
  • Injury
  • Ankle Injuries
  • Knee Injuries
  • Sports Injuries
  • Wrist Injury
  • Leg Injury
  • Hand Injury
  • Foot Injury
  • Arm Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the study completion, approximately 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout the study completion, approximately 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Client Satisfaction Questionnaire
Credibility and Expectancy Questionnaire
System Usability Scale
Secondary outcome measures
Acceptability of Treatment
Adherence to Pain Surveys
Feasibility of Outcome Assessments
+3 more
Other outcome measures
Center for Epidemiologic Study of Depression (CESD) Scale
Chronic Pain Acceptance Questionnaire (CPAQ)
Mindfulness
+9 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Skills-Based VRExperimental Treatment1 Intervention
Participants will complete daily skills-based Virtual Reality (VR) sessions for 8 weeks (an average of 6 minutes per day) to determine the feasibility of at-home VR technology to aid the recovery of acute orthopedic musculoskeletal injuries. The VR device software is equipped with pain-specific treatment modules (e.g., Pain Education, Relaxation/Interoception, Mindful Escapes, and Pain Distraction Games) derived from evidence-based principles of cognitive behavioral therapy (CBT), mindfulness, and pain neuroscience education.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
RelieveVRx
2022
N/A
~10

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,345 Total Patients Enrolled
Ryan A Mace, PhDPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation still seeking participants?

"That is correct. According to the information displayed on clinicaltrials.gov, this medical experiment continues to take in participants as of today; it was first posted in October 17th 2022 and last updated on March 13th 2023. In total, 10 patients are planned for recruitment from a single site."

Answered by AI

How many participants are being invited to join this experiment?

"Affirmative. Clinicaltrials.gov reflects that, since its initial posting on October 17th 2022, this clinical trial is actively looking for 10 volunteers from one location."

Answered by AI

What primary goal is this research attempting to achieve?

"This trial's primary outcome, assessed over the pre-intervention period of one week, is based on a Client Satisfaction Questionnaire. Other secondary outcomes include Motion Sickness & Nausea (determined by responses below midpoint), Feasibility of Recruitment (number of participants who agree to participate out of those approached) and Acceptability of Treatment (evaluated through module completion)."

Answered by AI
~4 spots leftby Apr 2025